Testicular Cancer Supportive Care Protocol

Testicular cancer is one of the most treatable cancers, with cure rates exceeding 95% even when spread. It primarily affects young men (ages 15-35). Treatment typically includes surgery (orchiectomy to remove the affected testicle) and may involve chemotherapy (especially cisplatin-based regimens like BEP) and/or radiation depending on the type and stage. While highly curable, treatments can cause significant side effects including nausea, fatigue, neuropathy, kidney effects, and long-term concerns about fertility and hormone levels.

CRITICAL: Testicular cancer treatment should ONLY be managed by an oncology team - typically a urologic oncologist and medical oncologist. The high cure rate depends on proper treatment. Do NOT delay or modify cancer treatment based on supplements. These supplements are for SUPPORTIVE CARE to help manage treatment side effects and support recovery - they are not cancer treatments. ALWAYS discuss supplements with your oncologist BEFORE taking them, as some may interfere with chemotherapy effectiveness. Fertility preservation (sperm banking) should be discussed BEFORE treatment.

* Vitamin D deficiency is common in cancer patients and optimizing levels may support immune function and bone health during treatment.

* Ginger has good evidence for reducing chemotherapy-induced nausea and vomiting when used alongside standard antiemetics.

* Omega-3 Fatty Acids have anti-inflammatory effects and may help maintain muscle mass during treatment.

* Probiotics help maintain gut health during chemotherapy and may reduce diarrhea.

* Glutamine may help reduce mucositis (mouth sores) and potentially peripheral neuropathy from chemotherapy.

* Coenzyme Q10 may provide some cardioprotection during chemotherapy.

* L-Carnitine may help protect kidneys from cisplatin toxicity and reduce fatigue.

* Selenium supports antioxidant defenses but should be used cautiously and not in high doses during active treatment.

Expected timeline: Supplements for side effect management start around treatment initiation. Recovery and follow-up extends for years (surveillance for recurrence). Long-term survivorship care is important.

Clinical Perspective

Testicular cancer: most common cancer in men 15-35. Types: Seminoma (40%), Non-seminomatous germ cell tumors (NSGCT - includes embryonal, yolk sac, choriocarcinoma, teratoma). Staging: Stage I (testis only), II (retroperitoneal nodes), III (distant metastases). Cure rates: Stage I >99%, Stage II 95%+, Stage III 70-80%+. Markers: AFP, beta-hCG, LDH.

CRITICAL: Treatment paradigm - extremely well-established, do not deviate. Stage I: orchiectomy + surveillance (most common) or adjuvant chemo/RT. Stage II-III: orchiectomy + chemotherapy (BEP: bleomycin, etoposide, cisplatin) +/- RPLND. Salvage: high-dose chemo with stem cell transplant. Side effects: BEP nephrotoxicity (cisplatin), pulmonary toxicity (bleomycin), neuropathy, ototoxicity, alopecia, nausea. Long-term: hypogonadism (may need testosterone), infertility, cardiovascular risk, secondary cancers. Fertility: sperm banking BEFORE chemo essential. Supplements: CONSULT ONCOLOGIST - some antioxidants may reduce chemo efficacy.

* Vitamin D (B-grade): Immune support; common deficiency. Meta-analysis: cancer outcomes (PMID: 29239487). Systematic review: treatment support (PMID: 26541826). 2000-4000 IU daily.

* Ginger (B-grade): 5-HT3 and NK1 effects. Meta-analysis: CINV benefit (PMID: 27478321). Clinical trial: added benefit (PMID: 22271130). 1-2g daily.

* Omega-3 Fatty Acids (B-grade): Anti-inflammatory; cachexia prevention. Systematic review: cancer treatment support (PMID: 31002788). 2-3g EPA+DHA daily.

* Probiotics (B-grade): Gut microbiome support. Meta-analysis: chemo-induced diarrhea (PMID: 31093849). 20-50 billion CFU daily.

* Glutamine (C-grade): Mucositis; neuropathy protection. Systematic review: chemo side effects (PMID: 24284016). 10-30g daily. Discuss with oncologist.

* CoQ10 (C-grade): Mitochondrial support; potential cardioprotection. Review: chemo cardiotoxicity (PMID: 27455394). 100-300mg daily.

* L-Carnitine (C-grade): Cisplatin nephroprotection. Systematic review: nephrotoxicity (PMID: 28475218). 2-3g daily.

* Selenium (C-grade): Antioxidant support. Review: cancer treatment (PMID: 28232943). 100-200mcg daily max.

Biomarker targets: Tumor markers (AFP, hCG, LDH - for surveillance), CBC, renal function (cisplatin), pulmonary function (bleomycin), testosterone level.

Protocol notes: Pre-treatment: sperm banking; baseline renal, pulmonary function. During treatment: standard antiemetics (5-HT3, NK1, steroids); hydration for cisplatin. Bleomycin: pulmonary function monitoring; avoid high FiO2. Post-treatment surveillance: years of follow-up with imaging, markers. Testosterone: check if symptoms of hypogonadism; replacement often needed. Cardiovascular: increased long-term risk; lipids, BP monitoring. Secondary malignancies: increased risk; appropriate screening. Supplement timing: generally avoid high-dose antioxidants same day as chemo (theoretical concern of reducing efficacy). Ginger: start 3 days before chemo cycle. Fertility: if bilateral orchiectomy or chemo damage, testosterone replacement needed but won't restore fertility. Mental health: young men with cancer, body image (orchiectomy), fertility concerns - support important.

View All Protocols